IK
Irvandeep Kaur
About Irvandeep Kaur
Data last updated:
Irvandeep Kaur is a Director at Jips Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Jips Pharmaceuticals Private Limited reported revenue of ₹27.63 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Jips Pharmaceuticals Private Limited U24304CH2017PTC041344 | Director | 17 Jan 2017 | 2017 | ₹27.63 Cr (FY 2023) | Active |
Board colleagues of Irvandeep Kaur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jagdeep Singh | 07672365 | Jips Pharmaceuticals Private Limited | Director |
| Parvinder Jit Singh | 07673268 | Jips Pharmaceuticals Private Limited | Director |
| Supreet Singh | 07511639 | Jips Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Irvandeep Kaur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Irvandeep Kaur
Irvandeep Kaur currently holds 1 directorship: Jips Pharmaceuticals Private Limited (Director, since 17 Jan 2017, revenue ₹27.63 Cr (FY 2023)).
Irvandeep Kaur was first appointed on 17 Jan 2017 as Director at Jips Pharmaceuticals Private Limited.
The current boards of Irvandeep Kaur's companies include Jagdeep Singh (Jips Pharmaceuticals Private Limited), Parvinder Jit Singh (Jips Pharmaceuticals Private Limited), Supreet Singh (Jips Pharmaceuticals Private Limited).